Cancer Progression and Prognosis
Cancer Metastasis
Cancer Resistance
Cancer Microenvironment
The Microbiome and Cancer
Important Alert: Cancer R&D/USG does not work with any 3rd parties to provide accommodation for this event. Please beware if you receive any e-mails or other communication from 3rd parties informing you about the accommodation options. The only trusted source of information about the accommodation is our website and communication from conference official e-mail address.
Welcome to the 2024 International Conference on Cancer Research and Development (Cancer R&D 2024), a prestigious three-day congress devoted to advancing the field of basic, preclinical, and translational cancer research. Hosted by United Scientific Group, a distinguished non-profit organization committed to the progression of cancer research, Cancer R&D serves as a platform to foster innovation, cultivate knowledge, and encourage meaningful connections and collaborations within the global cancer research community.
Koch Institute for Integrative Cancer Research At MIT, Howard Hughes Medical Institute
Co-founder & CEO
GV20 Therapeutics, MA
Novartis Institutes for Biomedical Research, MA
Van Andel Institute
MI
St. Jude Children's Research Hospital, TN
The University of Texas MD Anderson Cancer Center, TX
Founding Member, Whitehead Institute for Biomedical Research, Director, MIT Ludwig Center for Molecular Oncology, Cambridge
Dana-Farber Cancer Institute
Harvard Medical School, MA
Columbia University
New York
Director at Merck
Boston
Harvard T.H. Chan School of Public Health, Boston, USA
NCI, National Institutes of Health
MD
Executive Director & CSO, Gene Editing Institute, ChristianaCare
School of Medicine, Southern University of Science and Technology, China
National Cancer Institute, National Institutes of Health
Uniformed Services University of the Health Sciences, MD
University of California, San Francisco School of Medicine, CA
Cancer Metastasis
Cancer Resistance
Cancer Microenvironment
The Microbiome and Cancer
Cancer Genetics and Biomarkers
Precision Oncology
Computational Biology and AI in Cancer
Cancer Vaccines
Cancer Immunotherapies: Monotherapy and Combinations
Cellular Therapies for Cancer
Cancer Radiation Therapy
Targeted Therapy
Novel Drug Development in Cancer
Breast Cancer
Brain Tumors
Gastrointestinal Malignancies
Non–Small Cell Lung Cancer
Ovarian Cancer
Sarcoma Biology
Neuroendocrine Cancer
Having a great networking is inexpensive. It opens the doors for you and offers you a land of opportunity that might help you to spread your wings. Network face to face building a rapport with someone leading a solid connection in the research you are sailing. Cancer R&D 2024 brings that platform helping to create a foundational trust.
Research is to see what everybody else has seen but think what nobody else has thought. We at Cancer R&D 2024 created a platform to share that thought. Join us today to present the work to your peers in the world of Cancer Research.
Great achievements and improvements invariably involve the cooperation of many minds. Collaboration allows us to more than we are capable of knowing by ourselves and helps us to think out of box. At Cancer R&D 2024 you will find those minds to collaborate and achieve your goals.
The previous 8 editions of Cancer R&D conference were a great success and has brought together more than 900+ researchers from leading institutes and organizations.
United Scientific Group has geared up to a next level with its 9th annual meeting on Cancer Research & Drug Development during Nov 18-20, 2024
USG United Scientific Group
A non-profit organization
8105, Suite 112, Rasor Blvd
PLANO, TX 75024
© United Scientific Group.